Cargando…

Will the COVID-19 pandemic affect HCV disease burden?

Detalles Bibliográficos
Autores principales:	Kondili, Loreta A., Marcellusi, Andrea, Ryder, Stephen, Craxì, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256501/ https://www.ncbi.nlm.nih.gov/pubmed/32527655 http://dx.doi.org/10.1016/j.dld.2020.05.040

Ejemplares similares

The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries
por: Mennini, Francesco S., et al.
Publicado: (2021)

Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Impact of COVID-19 on global HCV elimination efforts
por: Blach, Sarah, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey
por: Kondili, Loreta A., et al.
Publicado: (2022)

A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions
por: Kondili, Loreta A., et al.
Publicado: (2022)

Optimization of hepatitis C virus screening strategies by birth cohort in Italy
por: Kondili, Loreta A., et al.
Publicado: (2020)

Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy
por: Mennini, Francesco Saverio, et al.
Publicado: (2014)

Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions
por: Rosato, Valerio, et al.
Publicado: (2022)

Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks’ Glecaprevir/Pibrentasvir Therapy
por: Andreoni, Massimo, et al.
Publicado: (2021)

Estimation of the number of HCV-positive patients in Italy
por: Gardini, Ivan, et al.
Publicado: (2019)

Economic Burden of Human Papillomavirus-Related Diseases in Italy
por: Baio, Gianluca, et al.
Publicado: (2012)

Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways
por: Mangia, Alessandra, et al.
Publicado: (2021)

Correction: Economic Burden of Human Papillomavirus-Related Diseases in Italy
por: Baio, Gianluca, et al.
Publicado: (2013)

HCV disease burden and population segments in Switzerland
por: Bihl, Florian, et al.
Publicado: (2021)

HPV Vaccination during the COVID-19 Pandemic in Italy: Opportunity Loss or Incremental Cost
por: Mennini, Francesco Saverio, et al.
Publicado: (2022)

Chronic Disease Burden - Nutrition and Lifestyle affecting Lives and Livelihoods in the Covid-19 Pandemic
por: Rajput-Ray, Minha
Publicado: (2022)

Hepatitis C Virus Micro-Elimination Plan in Southern Italy: The “HCV ICEberg” Project
por: Coppola, Carmine, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on HCV elimination in Spain
por: Buti, Maria, et al.
Publicado: (2021)

An ethical algorithm for rationing life-sustaining treatment during the COVID-19 pandemic
por: Savulescu, Julian, et al.
Publicado: (2020)

Factors Affecting Hesitancy to mRNA and Viral Vector COVID-19 Vaccines among College Students in Italy
por: Salerno, Laura, et al.
Publicado: (2021)

Meet–Test–Treat for HCV management: patients’ and clinicians’ preferences in hospital and drug addiction services in Italy
por: Andreoni, Massimo, et al.
Publicado: (2022)

HCV hotline facilitates Hepatitis C elimination during the COVID‐19 pandemic
por: Hartl, Lukas, et al.
Publicado: (2022)

Mental health burden for Chinese middle school students affected by the COVID-19 pandemic
por: Chen, Qiaohong, et al.
Publicado: (2020)

Chronic Hepatitis C Virus (HCV) Disease Burden and Cost in the United States
por: Razavi, Homie, et al.
Publicado: (2013)

Understanding the Burden of the COVID-19 Pandemic for People With Kidney Disease
por: Wetmore, James B.
Publicado: (2021)

Preventing a Post-Pandemic Double Burden of Disease in the COVID-19 Pandemic
por: Chan, Amy Hai Yan, et al.
Publicado: (2021)

Forecasting Hepatitis C liver disease burden on real‐life data. Does the hidden iceberg matter to reach the elimination goals?
por: Kondili, Loreta A., et al.
Publicado: (2018)

Surveillance is underestimating the burden of the COVID-19 pandemic
por: Alwan, Nisreen A
Publicado: (2020)

NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients
por: Bellocchi, Maria Concetta, et al.
Publicado: (2019)

The psychological burden of the COVID-19 pandemic severity
por: Le, Kien, et al.
Publicado: (2021)

The Impact of COVID-19 Vaccination on the Italian Healthcare System: A Scenario Analysis
por: Marcellusi, Andrea, et al.
Publicado: (2022)

Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress
por: Blach, Sarah, et al.
Publicado: (2023)

Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis
por: Marcellusi, Andrea, et al.
Publicado: (2018)

The burdens of poverty during the COVID-19 pandemic
por: Petersen, Julia, et al.
Publicado: (2022)

Caregiver burden and COVID-19: How epilepsy caregivers experienced the pandemic
por: Viny, Mikayla, et al.
Publicado: (2023)

HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality
por: Mühlberger, Nikolai, et al.
Publicado: (2009)

Somatic burden in Russia during the COVID-19 pandemic
por: Zolotareva, Alena, et al.
Publicado: (2023)

Patterns of Healthcare Utilization Among Veterans Infected With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) and Coinfected With HIV/HCV: Unique Burdens of Disease
por: Katrak, Shereen, et al.
Publicado: (2016)

The impact of COVID-19 pandemic control measures on HCV treatment initiation in British Columbia, Canada
por: Janjua, Naveed, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qupf4hkbg1a0t8cccprkvlu4ic